Alpha-Fetoprotein and Novel Tumor Biomarkers as Predictors of Hepatocellular Carcinoma Recurrence after Surgery: A Brilliant Star Raises Again
Alpha-fetoprotein (AFP), des-γ-carboxy prothrombin (DCP), and lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) have been developed with the intent to detect hepatocellular carcinoma (HCC) and for the surveillance of at-risk patients. However, at present, none of these tests can be recomme...
Main Authors: | Quirino Lai, Fabio Melandro, Rafael S. Pinheiro, Andrea Donfrancesco, Bashir A. Fadel, Giovanni B. Levi Sandri, Massimo Rossi, Pasquale B. Berloco, Fabrizio M. Frattaroli |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/893103 |
Similar Items
-
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
by: Xiaoping Wang, et al.
Published: (2018-01-01) -
Alpha-fetoprotein and immunotherapy for hepatocellular carcinoma
by: Alisa, A. A. H. I.
Published: (2012) -
Diagnostic value of alpha-fetoprotein for hepatocellular carcinoma
by: Julio C Hernández, et al. -
Value of combined measurement of alpha-fetoprotein and alpha-fetoprotein L3% in the diagnosis of hepatocellular carcinoma
by: GUAN Guiwen
Published: (2019-07-01) -
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
by: Chao-Wei Lee, et al.
Published: (2019-10-01)